GDNF and alcohol use disorder

Segev Barak*, Somayeh Ahmadiantehrani, Marian L. Logrip, Dorit Ron

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has been extensively studied for its role in the development and maintenance of the midbrain dopaminergic system, although evidence suggests that GDNF also plays a role in drug and alcohol addiction. This review focuses on the unique actions of GDNF in the mechanisms that prevent the transition from recreational alcohol use to abuse. Specifically, we describe studies in rodents suggesting that alcohol acutely increases GDNF expression in the ventral tegmental area, which enables the activation of the mitogen-activated protein kinase signaling pathway and the gating of alcohol intake. We further provide evidence to suggest that GDNF acts in the ventral tegmental area via both nongenomic and genomic mechanisms to suppress alcohol consumption. In addition, we describe findings indicating that when this endogenous protective pathway becomes dysregulated, alcohol intake levels escalate. Finally, we describe the potential use of GDNF inducers as a novel therapeutic approach to treat alcohol use disorder.

Original languageEnglish
Pages (from-to)335-343
Number of pages9
JournalAddiction Biology
Volume24
Issue number3
DOIs
StatePublished - May 2019

Keywords

  • GDNF
  • addiction
  • alcohol
  • ethanol
  • mesolimbic system
  • nucleus accumbens
  • ventral tegmental area

Fingerprint

Dive into the research topics of 'GDNF and alcohol use disorder'. Together they form a unique fingerprint.

Cite this